October 31, 2014
Prevacus

Photo:

Jacob VanLandingham

Profile

Prevacus

| 2/22/2013

Neuroscientist Jacob VanLandingham, an assistant professor at Florida State University's college of medicine, began research in 2004 to develop a drug to treat concussions. "We recognized within the last few years between military and sports injuries, that concussions have become an epidemic, so we made an effort to find something for this population." The result: VanLandingham recently patented a neurosteroid drug and launched a company, Prevacus, at Tallahassee’s Innovation Park, for work on funding, preclinical trials and product refinement. The development has sparked interest from the Department of Defense and from the University of Pittsburgh Medical Center, a professional sports affiliate that has agreed to help with clinical trials, which could begin within the next 18 to 36 months.

Tags: Trendsetters, Healthcare, Research & Development

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single ditgital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Colleges Are Tracking When Students Work Out at Rec Centers
Colleges Are Tracking When Students Work Out at Rec Centers

Officials on college campuses are turning to usage data and student feedback to shape fitness programs, hoping it will entice more students to develop healthy habits. 

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Do you give - or get - an annual performance review?

  • Yes - and I hate it
  • Yes - and it's OK - there's some value in the exercise
  • Yes - and I find it very valuable
  • No (thank goodness)

See Results

Ballot Box
Subscribe